Innovita Biological Technology Co., Ltd.

XSSC:688253 Stock Report

Market Cap: CN¥6.0b

Innovita Biological Technology Future Growth

Future criteria checks 6/6

Innovita Biological Technology is forecast to grow earnings and revenue by 32.4% and 29.4% per annum respectively. EPS is expected to grow by 32.3% per annum. Return on equity is forecast to be 23.4% in 3 years.

Key information

32.4%

Earnings growth rate

32.3%

EPS growth rate

Medical Equipment earnings growth23.5%
Revenue growth rate29.4%
Future return on equity23.4%
Analyst coverage

Low

Last updated08 Sep 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

XSSC:688253 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20261,457706N/A6961
12/31/20251,136532N/A5331
12/31/2024874400N/A3991
6/30/2024676303384409N/A
3/31/2024625266390413N/A
12/31/2023478174243260N/A
9/30/2023487149180219N/A
6/30/20234201204691N/A
3/31/20235121782785N/A
12/31/202244715169126N/A
9/30/202237314362100N/A
6/30/202236013364100N/A
3/31/2022267784887N/A
12/31/202132712043106N/A
12/31/20201,037571563640N/A
12/31/2019138212535N/A
12/31/20187917813N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 688253's forecast earnings growth (32.4% per year) is above the savings rate (2.9%).

Earnings vs Market: 688253's earnings (32.4% per year) are forecast to grow faster than the CN market (23% per year).

High Growth Earnings: 688253's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 688253's revenue (29.4% per year) is forecast to grow faster than the CN market (13.1% per year).

High Growth Revenue: 688253's revenue (29.4% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 688253's Return on Equity is forecast to be high in 3 years time (23.4%)

Discover growth companies

7D

1Y

7D

1Y

7D

1Y